AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas –immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

1 North Waukegan Road
North Chicago, IL 60064

Visit website

Stock Symbol: ABBV
Stock Exchange: NYSE

Together, we break through.

Our principles are at the Heart of our Company. Operating as one AbbVie team, we care deeply for our patients, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. In everything we do, we invest and innovate relentlessly to tackle unmet needs, creating new medicines and healthcare approaches for a healthier world.

How we work with each other and achieve results matters. That’s why we’ve been honored to receive some of the most prestigious ratings and recognitions in the industry, including being named on more than 40 Great Place to Work and Top Employer lists and FORTUNE “100 Best Companies to Work For.”

Click here to learn more about our principles.

NEWS

Drug Development

AbbVie Resumes Multiple Myeloma Trial After FDA Lifts Partial Hold

The partial clinical hold was lifted after the company revised the study protocol for the trial. The partial clinical hold remains on other multiple myeloma trials involving venetoclax.

June 24, 2019

3 min read

Alex Keown

BioMidwest

AbbVie Employees to Help Underserved Communities in Sixth-Annual “Week of Possibilities”

Approximately 9,000 employees participate in volunteer activities to update schools and community centers all over the world benefitting more than 70,000 students and 50,000 community members

June 10, 2019

4 min read

BioForest

Top Life Science Companies Hiring Now in June

According to a BioSpace survey, almost 70% of respondents are likely to look for a new job in the 12 months. The question is, why? Of those planning to look for a new job, 54% said they wanted new challenges and 42% said they wanted more rewarding opportunities. How about you? Are you ready to look for a job with more challenges and rewarding opportunities?

June 3, 2019

1 min read

BioSpace Staff

Zeposia recieved top line results in the ulcerativ

BioMidwest

Takeda’s Entyvio Superior to Humira in Ulcerative Colitis

The new exploratory data indicated that a larger proportion of patients receiving Entyvio had a clinical response at week 14 compared to those receiving Humira.

May 20, 2019

2 min read

Mark Terry

Drug Development

AbbVie Halts Brain Tumor Study Due to Lack of Survival Benefits

An Independent Data Monitoring Committee recommended the trial be stopped because of lack of survival benefit for patients receiving the drug compared to placebo.

May 17, 2019

2 min read

Mark Terry

Policy

Boehringer Ingelheim and AbbVie Resolve Humira Biosimilar Patent Litigation

Under the terms of the deal, AbbVie will grant Germany-based Boehringer Ingelheim a non-exclusive license for Cyltezo, its biosimilar to Humira.

May 14, 2019

2 min read

Alex Keown

Business

How Much Did These Pharma CEOs Earn in 2017?

For those select few who achieve the role of chief executive officer of a multi-national corporation, the compensation packages are typically quite large – especially when compared to the average salaries of company employees.

May 2, 2019

2 min read

Alex Keown

Policy

AbbVie’s Mavyret Approved for Hep C in Pediatric and Adolescent Patients

The FDA gave the nod to AbbVie’s Mavyret for all six strains of hepatitis C in children ages 12 to 17 years. The drug was approved for adults 18 years or older in 2017.

May 1, 2019

3 min read

Mark Terry

BioCapital

Top Life Science Companies Hiring Now in May

According to a recent BioSpace survey, 93% of respondents are open to a new job for the right opportunity. Are you one of the 93%? If so, keep your eyes open for those opportunities and don’t stop looking. You never know what may come your way!

April 30, 2019

1 min read

Editorial Staff

JOBS